In Short:Sun Pharmaceutical Industries has completed the merger with Taro Pharmaceutical Industries, ending a long feud. Taro will be delisted from NYSE and will...
In Short:Sun Pharmaceutical Industries predicts a high single-digit growth in revenue for the current fiscal year. Managing Director Dilip Shanghvi mentioned that the company...
